Cannabis Market Brings in Significant Tax Revenues

Tuesday, February 21, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, February 21, 2017 /PRNewswire/ --

The cannabis market is experiencing significant growth due to the accelerating

pace of cannabis legalization in the United States. According to a research report published by Technavio, the global legal cannabis market will grow at an impressive CAGR of around 37% between 2016 and 2020. The report
indicated that rapid adoption of cannabis by individual consumers as well as economic benefits of legalizing cannabis are some of the pivotal factors that drive the growth in the market. Petrone Worldwide, Inc. (OTC: PFWI), Medical Marijuana Inc. (OTC: MJNA) Marijuana Company of America Inc. (OTC: MCOA), Terra Tech Corporation (OTC: TRTC), American Cannabis Company Inc. (OTC: AMMJ)

The report also indicated the several other benefits of legalizing cannabis: "The high tax revenues from the purchase of marijuana for recreational purposes have led governments of various countries to legalize marijuana. The legalization of marijuana for recreational purpose will increase at a rapid pace with the increasing number of countries allowing the possession of a limited quantity of marijuana. Such developments have propelled vendors to come up with legal recreational cannabis stores, which will further propel the growth of this segment in the coming years."

Petrone Worldwide, Inc. (OTCQB: PFWI) just announced this morning that, "the Company is in the process of entering the cannabis market in the very near future. PFWI will use their extensive knowledge of transportation and logistics to facilitate the worldwide delivery of cannabis related products.

Victor Petrone, CEO and founder of PFWI, says, "Petrone Worldwide has been contemplating entering the cannabis market for several months and we feel that now is the time to make our move. After recent legalization votes passed in various states, we feel that this will only open the door for more cannabis related products that need to be shipped all over the world. This is merely a diversification of what Petrone Worldwide currently does and it will surely boost not only Company revenues, but also long-term shareholder value."

Petrone Worldwide, Inc. will continue to update both the public and shareholders as the Company makes this exciting transition into the cannabis market."

Development-stage company that operates in cannabis and industrial hemp, Medical Marijuana Inc. (OTC: MJNA) owns 100 percent of HempMedsŪ Brasil. HempMedsŪ Brasil currently has three cannabis products approved for importation into Brazil as a prescription medication. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system. As of 2015, ANVISA has allowed cannabidiol treatments for any medical condition a doctor sees could help the patient. HempMedsŪ Brasil has had doctor prescriptions for Epilepsy, Parkinson's, Alzheimer's, Cancer, Autism, Multiple Sclerosis and Chronic Pain to date and is working on additional approvals for multiple indications.

Innovative cannabis and hemp marketing and distribution Company, Marijuana Company of America Inc. (OTC: MCOA) announced it has entered into a non-binding Letter of Intent while performing due diligence to finalize a joint venture agreement with Bougainville Ventures, Inc. for the purpose of housing tenant growers engaging in the cultivation, processing and commercial availability of legal marijuana in the State of Washington. "We are looking forward to getting seed in the ground and ramping up this partnership with Andy Jagpal and Bougainville Ventures. This partnership further strengthens our supply chain and enables MCOA to produce the highest quality products at the lowest possible prices," said President and Chief Executive Officer, Donald Steinberg.

Vertically integrated cannabis-focused agriculture company, Terra Tech Corporation (OTCQX: TRTC) operates through two segments: Hydroponic Produce and Cannabis Products. The Company, through its subsidiary, GrowOp Technology Ltd., is engaged in the design, marketing and sale of hydroponic equipment. It is also a retail seller of locally grown hydroponic produce, herbs, and floral products through its subsidiary, Edible Garden Corporation. It intends to operate medical marijuana cultivation, production and dispensary facilities in Nevada through its subsidiaries, MediFarm LLC. Through its subsidiary, IVXX, Inc., it produces and sells a line of cannabis flowers and cigarettes, among others. The hydroponic produce segment consists of Edible Garden's business and operations.

Provider of consulting and product solutions for the medical, adult use and low-THC regulated cannabis markets both nationally and internationally, American Cannabis Company Inc. (OTCQB: AMMJ) has secured its sixth client in Pennsylvania. The Company will work with this client to plan, deploy and remotely oversee the client's retail dispensing, cultivation and infused product manufacturing operations within the city of Philadelphia. Furthermore to the Company's consulting engagement, the Company will also be taking an equity interest in the client's project and operations. "We are excited to be working with this particular client, as well as collaborating with them by taking an equity position in their business. The Company is actively exploring the development of hybrid relationships like this, that generate both consulting revenues and the opportunity for recurring profits from our equity interest. We feel that this new strategy will provide a beneficial long-term value to both our clients and our shareholders," said Chief Executive Officer of American Cannabis Company, Terry Buffalo.

Please SIGN UP NOW at To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. only regurgitates financial or corporate news through our unique financial newswire and media platform. has been compensated three thousand seven hundred fifty dollars for financial news dissemination and pr services by a third party non affiliate for petrone worldwide, inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use.

Please visit:

For further information: Media Contact: , +1-877-601-1879


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store